Acacia Research Corporation reported consolidated revenue of $10.1 million for the quarter, a decrease compared to $15.9 million in the third quarter of 2022. The company recorded $12.2 million of net realized and unrealized gains during the quarter and a GAAP net income of $1.6 million, or a net loss of $0.03 per diluted share.
Consolidated revenue for the quarter was $10.1 million, compared to $15.9 million in the third quarter of 2022.
Net realized and unrealized gains of $12.2 million were recorded during the quarter.
A wholly owned subsidiary entered into an agreement to sell its shares of Arix Bioscience PLC for $57.1 million, expected to be completed in Q1 2024.
Acquired a majority stake in Benchmark Energy II LLC, an independent oil and gas company.
Acacia is focused on acquiring and operating attractive businesses across the industrial, healthcare, energy, and mature technology sectors.
Visualization of income flow from segment revenue to net income